Korea To Toughen Co-Bioequivalence Study System Amid Generic Quality Issue
Revised Pharma Act Clears First Parliamentary Hurdle
Executive Summary
Legislation that could thin the crowded generic market clears first parliamentary hurdle as brand and generic firms alike react to the recent generic quality issue raised by recent manufacturing incidences at some South Korean pharma firms.